These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4348402)

  • 1. FL 1060: a new beta-lactam antibiotic with novel properties.
    Greenwood D; O'Grady F
    J Clin Pathol; 1973 Jan; 26(1):1-6. PubMed ID: 4348402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens.
    Greenwood D; Brooks HL; Gargan R; O'Grady F
    J Clin Pathol; 1974 Mar; 27(3):192-7. PubMed ID: 4598880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing of Escherichia coli by beta-lactams at different inocula.
    Tam VH; Ledesma KR; Chang KT; Wang TY; Quinn JP
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):166-71. PubMed ID: 19304437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light and electron microscopy of the early response of Escherichia coli to a 6beta-amidinopenicillanic acid (FL 1060).
    Melchior NH; Blom J; Tybring L; Birch-Andersen A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Aug; 81(4):393-407. PubMed ID: 4358286
    [No Abstract]   [Full Text] [Related]  

  • 5. The two sites of penicillin action in Escherichia coli.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Dec; 128(6):791-4. PubMed ID: 4358124
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of osmolality on the response of Escherichia coli to mecillinam.
    Greenwood D
    Antimicrob Agents Chemother; 1976 Nov; 10(5):824-6. PubMed ID: 795371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting.
    Stainton SM; Thabit AK; Kuti JL; Aslanzadeh J; Nicolau DP
    Clin Microbiol Infect; 2017 Aug; 23(8):581-582. PubMed ID: 28254605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
    Zaremba M; Zukowska-Nytko K; Borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of Escherichia coli resistance to amidine penicillin].
    Zapasnik M; Morris-Rostkowska W; Chojnowski W
    Acta Pol Pharm; 1976; 33(5):663-4. PubMed ID: 187015
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial kinetics of beta-lactam antibiotics against Escherichia coli.
    Tsuji A; Hamano S; Asano T; Nakashima E; Yamana T; Mitsuhashi S
    J Pharm Sci; 1984 Oct; 73(10):1418-22. PubMed ID: 6389825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of penicillin-binding protein 5 (PBP5) sensitises Escherichia coli cells to beta-lactam agents.
    Sarkar SK; Chowdhury C; Ghosh AS
    Int J Antimicrob Agents; 2010 Mar; 35(3):244-9. PubMed ID: 20047819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug resistance and beta-lactam antibiotic inactivation by bacteria isolated from clinical materials].
    Tomioka H; Uchida H; Minoura Y; Kameoka Y; Hayashi N
    Rinsho Byori; 1974 Oct; 22(10 Suppl):349. PubMed ID: 4615196
    [No Abstract]   [Full Text] [Related]  

  • 17. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.
    Tybring L; Melchior NH
    Antimicrob Agents Chemother; 1975 Sep; 8(3):271-6. PubMed ID: 170856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of O8-antigen in altering beta-lactam antibiotic susceptibilities in Escherichia coli.
    Sarkar SK; Ghosh AS
    FEMS Microbiol Lett; 2008 May; 282(1):59-64. PubMed ID: 18328080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment.
    Kjeldsen TS; Sommer MO; Olsen JE
    BMC Microbiol; 2015 Mar; 15():63. PubMed ID: 25888392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.